Parkside Financial Bank & Trust’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-160
Closed -$3.18K – 2124
2023
Q1
$3.18K Sell
160
-70
-30% -$1.21K ﹤0.01% 1535
2022
Q4
$3.13K Sell
230
-15
-6% -$209 ﹤0.01% 1517
2022
Q3
$3K Buy
245
+219
+842% +$3.25K ﹤0.01% 1485
2022
Q2
$0 Sell
26
-102
-80% -$1.77K ﹤0.01% 1997
2022
Q1
$3K Sell
128
-73
-36% -$1.42K ﹤0.01% 1545
2021
Q4
$4K Buy
201
+70
+53% +$1.87K ﹤0.01% 1447
2021
Q3
$4K Sell
131
-9
-6% -$336 ﹤0.01% 1387
2021
Q2
$6K Buy
140
+9
+7% +$352 ﹤0.01% 1197
2021
Q1
$5K Hold
131
– – ﹤0.01% 1239
2020
Q4
$6K Buy
131
+82
+167% +$3.09K ﹤0.01% 1072
2020
Q3
$2K Buy
49
+16
+48% +$517 ﹤0.01% 1242
2020
Q2
$1K Hold
33
– – ﹤0.01% 1427
2020
Q1
$1K Sell
33
-8
-20% -$337 ﹤0.01% 1365
2019
Q4
$2K Hold
41
– – ﹤0.01% 1276
2019
Q3
$2K Hold
41
– – ﹤0.01% 1243
2019
Q2
$2K Buy
+41
New +$1.59K ﹤0.01% 1252

Other funds holding CSII

Parkside Financial Bank & Trust's CSII Position: Q2 2023 in Review

Parkside Financial Bank & Trust sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 160 shares — an estimated $3.18K sold.

Parkside Financial Bank & Trust first reported a position in CSII in Q2 2019 and held it in 16 quarters. The position peaked at $6K in Q2 2021. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • Parkside Financial Bank & Trust reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 160 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $3.18K.
  • Parkside Financial Bank & Trust first reported a position in Cardiovascular Systems, Inc. in Q2 2019 and held it in 16 quarters.
  • Parkside Financial Bank & Trust's Cardiovascular Systems, Inc. position peaked at $6K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2023, filed 15 Aug 2023.